dihexa side effects wholisticresearch Di(2-ethylhexyl)phthalate (DEHP) WholisticResearch: Cutting-Edge Nootropics Research

Acknowledgements The study is supported by a Singapore EDB-IPP grant (grant number: RL2012035)

Both remain in phase 3 clinical development programs [16]: Cagrilintide Status: Phase 3 trials ongoing for CagriSema (cagrilintide + semaglutide combination) Expected approval timeline: 2027-2028 for the combination product Monotherapy development pathway unclear Retatrutide Status: Phase 3 trials initiated in 2024-2025 Monotherapy development for obesity and metabolic dysfunction Expected approval timeline: 2028-2029 if trials succeed This regulatory status means any use of these compounds, whether individually or in cagrilintide dosage with retatrutide combinations, occurs in research contexts or through off-label prescribing once (if) individual approvals are obtained

People following vegetarian or vegan diets may also need a more reliable source, since B12 is primarily found in animal products

S.KavanaghD